AIM/NIOX (AIM/NIOX)

London Stock Exchange AIM: AIM/NIOX · GBX

GBX 68.0

-1.00 (-1.4%)· Recorded snapshot

Market cap	286.2M
Revenue (ttm)	47.5M
Net income (ttm)	7M
EPS (ttm)	GBX 0.02
Shares out	420.9M
P/E (trailing)	41.7x
P/E (forward)	21.4x
Dividend	GBX 0.02 (2.28%)
Volume	890,957
Beta	-0.04

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 47.5M
Net income (ttm): 7M
EPS (ttm): GBX 0.02
P/E (trailing): 41.7x
P/E (forward): 21.4x
Market cap: 286.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E21.4

P25 n/aP50 n/aP75 n/a

Trailing P/E41.7

P25 n/aP50 n/aP75 n/a

ROE10.7

P25 n/aP50 n/aP75 n/a

ROIC12.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AIM/NIOX indicators

Market & fundamental data

Available fields

247

Groups with data

Currency

GBP

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United Kingdom
Country code	UK
Earnings date	2026-09-29
Employees	97
Employees change	6
Employees growth	6.59%
Enterprise value	GBX 270.1M
Exchange	London Stock Exchange AIM
Financial currency	GBP
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2006
Industry	Medical Devices
Is primary listing	Yes
ISIN number	GB00BJVD3B28
Last earnings date	2026-09-29
Last refreshed	2026-10-28
Market cap	GBX 286.2M
Next earnings date	2026-12-24
Price	GBX 68.00
Price currency	GBX
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	aim/NIOX
Website	https://www.niox.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	36.81x
Average P/E ratio (5Y)	31.56x
Earnings yield	2.4%
EV/Earnings	39.19x
EV/EBIT	26.37x
EV/EBITDA	18.66x
EV/FCF	22.67x
EV/Sales	5.77x
FCF / EV yield	4.41%
FCF yield	4.17%
Forward P/E	21.43x
Graham number	24.053
Graham upside	-65.54%
Industry forward P/E	13.63x
Industry P/E	21.46x
Lynch fair value	GBX 8.15
Lynch upside	-88.32%
P/(FCF - SBC) ratio	24.61x
P/(OCF - SBC) ratio	24.2x
P/B ratio	4.39x
P/E ratio	41.7x
P/FCF ratio	24x
P/OCF ratio	23.61x
P/S ratio	6.11x
PEG ratio	0.57x
Price / tangible book value	7.22x
Price/EBITDA ratio	20.45x
Sector forward P/E	14.49x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	21.89%
EBITDA margin	29.89%
Effective tax rate	38.05%
FCF margin	25.47%
Gross margin	69.47%
Operating margin	21.89%
Pretax margin	23.79%
Profit margin	14.74%
Profit per employee	GBX 72,165
Profitable quarters	3
Profitable years	5
Revenue per employee	GBX 489,691
ROA	9.02%
ROA (5Y)	3.34%
ROCE	15.69%
ROE	10.73%
ROE (5Y)	9.93%
ROIC	12.89%
ROIC (5Y)	4.43%
SBC / revenue	0.63%
Tax / revenue	9.05%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	61.16%
EPS growth (Q)	-0.72%
EPS growth (QoQ)	449.58%
EPS growth 3Y	-23.49%
EPS growth years	1
FCF growth	-31.64%
FCF growth (Q)	-45.59%
FCF growth (QoQ)	-55.95%
FCF growth 3Y	22.39%
Gross profit growth	4.93%
Gross profit growth (Q)	-3.95%
Gross profit growth 3Y	14.13%
Gross profit growth 5Y	15.15%
Net income growth	57.3%
Net income growth (QoQ)	436.36%
Net income growth 3Y	-24.24%
Net income growth years	1
OCF growth	-30.31%
OCF growth (Q)	-45.59%
OCF growth (QoQ)	-56.98%
OCF growth 3Y	22.45%
Operating income growth	22.35%
Operating income growth (Q)	-5.17%
Operating income growth 3Y	79.44%
Revenue growth	8.2%
Revenue growth (Q)	-4.76%
Revenue growth (QoQ)	2.13%
Revenue growth 10Y	23.62%
Revenue growth 3Y	14.92%
Revenue growth 5Y	14.73%
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	GBX -200,000
Depreciation and amortization	GBX 3.8M
EBIT	GBX 10.4M
EBITDA	GBX 14.2M
EPS	GBX 0.02
FCF per share	GBX 0.03
Financing cash flow	GBX -6.7M
Free cash flow	GBX 12.1M
Free cash flow minus SBC	GBX 11.8M
Gross profit	GBX 33M
Income taxes	GBX 4.3M
Investing cash flow	GBX -700,000
Net borrowing	GBX -700,000
Net cash flow	GBX 5M
Net income	GBX 7M
Operating cash flow minus SBC	GBX 12M
Operating income	GBX 10.4M
Revenue	GBX 47.5M
Stock-based compensation	GBX 300,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	26.18
Book value per share	GBX 0.16
Debt / EBITDA	0.05
Debt / equity	0.01
Debt / FCF	0.06
Goodwill	GBX 4.6M
Long-term assets	GBX 41.8M
Long-term liabilities	GBX 200,000
Net cash (debt)	GBX 16.1M
Net cash / market cap	5.54%
Net cash growth	51.89%
Net debt / EBITDA	-1.13
Net debt / equity	-0.24
Net debt / FCF	-1.33
Piotroski F-Score	6
Property, plant and equipment	GBX 1M
Shareholders' equity	GBX 66.1M
Tangible book value	GBX 40.2M
Tangible book value per share	GBX 0.10
Total assets	GBX 73.1M
Total cash	GBX 16.8M
Total debt	GBX 700,000
Total liabilities	GBX 7M
WACC	4.04%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.66
Current assets	GBX 31.3M
Current liabilities	GBX 6.8M
Current ratio	4.6
Inventory turnover	2.48
Net working capital	GBX 8.2M
Quick ratio	3.32
Working capital	GBX 24.5M
Working capital turnover	2.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.34%
Dividend growth	24%
Dividend growth years	1
Dividend payment date	2026-06-22
Dividend payment years	4
Dividend payout frequency	Annual
Dividend per share	GBX 0.02
Dividend yield	2.28%
Ex-dividend date	2026-05-21
FCF payout ratio	53.91%
Last dividend	GBX 0.02
Payout ratio	92.86%
Shareholder yield	5.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-19.05%
10Y return CAGR	-1.16%
10Y total return	-11.01%
150-day SMA	GBX 62.72
1D price change	-1.45%
1M price change	3.66%
1M total return	3.66%
1W price change	-1.45%
1W total return	-1.45%
1Y price change	-3.13%
1Y return CAGR	-0.63%
1Y total return	-0.63%
20-day SMA	GBX 67.80
200-day SMA	GBX 63.07
3M price change	5.26%
3M total return	5.26%
3Y price change	8.97%
3Y return CAGR	4.89%
3Y total return	15.41%
50-day SMA	GBX 67.41
50-day SMA vs 200-day SMA	50over200
52-week high	GBX 80.00
52-week high date	2026-10-22
52-week low	GBX 53.84
52-week low date	2026-03-23
5Y price change	59.81%
5Y return CAGR	11.93%
5Y total return	75.68%
6M total return	2.58%
All-time high	GBX 356.00
All-time high date	2015-09-03
All-time low	GBX 12.50
All-time low date	2020-03-23
Average true range (ATR)	GBX 3.08
Average volume	1.1M
Beta (1Y)	-0.1
Beta (2Y)	0.22
Beta (5Y)	-0.04
Change from 52-week high	-15%
Change from 52-week low	26.3%
Change from all-time high	-80.9%
Change from all-time low	444%
Change from open	-2.58%
Day's gap	1.16%
Dollar volume	GBX 60.6M
High price	GBX 69.80
Low price	GBX 67.00
Monthly RSI	53.13
Open price	GBX 69.80
Position in 52-week range	35.71%
Previous close	GBX 69.00
Price vs 150-day SMA	8.42%
Price vs 20-day SMA	0.29%
Price vs 200-day SMA	7.82%
Price vs 50-day SMA	0.88%
Relative volume	0.8
RSI	51.37
Sharpe ratio	0.07
Sharpe ratio (3Y)	0.17
Sharpe ratio (5Y)	0.38
Sortino ratio	0.29
Sortino ratio (3Y)	0.41
Sortino ratio (5Y)	0.72
Volume	891K
Weekly RSI	57.43
YTD price change	2.41%
YTD total return	5.05%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	331.6M
Shares change (QoQ)	-0.08%
Shares change (YoY)	-3.34%
Shares held by insiders	3.66%
Shares held by institutions	73.13%
Shares outstanding	420.9M

Deeper analysis on AIM/NIOX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AIM/NIOX report

Is a complete AIM/NIOX research report available?

No complete published report is available for aim/NIOX (AIM/NIOX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/NIOX (AIM/NIOX)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/NIOX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/NIOX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AIM/NIOX

Frequently asked questions